6533b833fe1ef96bd129c442
RESEARCH PRODUCT
ERCP and MRCP in the Differentiation of Pancreatic Tumors
G. LayerHenning E. AdamekDirk HartmannDieter SchillingBoris BasslerJürgen F. Riemannsubject
Malemedicine.medical_specialtySensitivity and SpecificityDiagnosis DifferentialCystadenoma MucinousPancreatic cancerHumansMedicineEndoscopy Digestive SystemPancreasCholangiopancreatography Endoscopic RetrogradeMagnetic resonance cholangiopancreatographyEndoscopic retrograde cholangiopancreatographymedicine.diagnostic_testbusiness.industryGastroenterologyIslet cell tumorsMagnetic resonance imagingGeneral MedicineAdenoma Islet Cellmedicine.diseaseMagnetic Resonance ImagingPancreatic NeoplasmsFemaleRadiologybusinessdescription
The introduction of endoscopic retrograde cholangiopancreatography (ERCP) in the early 1970s provided gastroenterologists with a number of diagnostic as well as therapeutic possibilities for examining biliopancreatic systems. In the meantime, magnetic resonance cholangiopancreatography presents a non-invasive alternative to diagnostic ECRP providing the advantage of a lower rate of possible complications. This article addresses the two methods presently available for differentiating pancreatic tumors. The objective of this article is to describe the advantages and disadvantages as well as the possibilities inherent in both methods.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2004-08-05 | Digestive Diseases |